Cardinal Health, Inc. $CAH Shares Purchased by Legal & General Group Plc

Legal & General Group Plc grew its holdings in Cardinal Health, Inc. (NYSE:CAH) by 2.0% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,349,767 shares of the company’s stock after acquiring an additional 45,812 shares during the period. Legal & General Group Plc owned about 0.98% of Cardinal Health worth $394,761,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in CAH. MassMutual Private Wealth & Trust FSB lifted its stake in shares of Cardinal Health by 3.6% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,767 shares of the company’s stock worth $297,000 after purchasing an additional 62 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its stake in shares of Cardinal Health by 0.4% in the second quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 17,805 shares of the company’s stock valued at $2,991,000 after buying an additional 69 shares in the last quarter. Perigon Wealth Management LLC raised its holdings in shares of Cardinal Health by 3.2% during the 2nd quarter. Perigon Wealth Management LLC now owns 2,314 shares of the company’s stock valued at $389,000 after buying an additional 72 shares during the period. Community Bank & Trust Waco Texas lifted its position in Cardinal Health by 1.3% during the 2nd quarter. Community Bank & Trust Waco Texas now owns 5,598 shares of the company’s stock worth $940,000 after acquiring an additional 74 shares in the last quarter. Finally, Atlantic Edge Private Wealth Management LLC boosted its holdings in Cardinal Health by 75.0% in the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after acquiring an additional 75 shares during the period. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Stock Performance

Shares of NYSE:CAH opened at $209.27 on Friday. The company’s fifty day moving average is $171.23 and its two-hundred day moving average is $161.11. Cardinal Health, Inc. has a 1-year low of $114.60 and a 1-year high of $210.32. The stock has a market capitalization of $49.72 billion, a price-to-earnings ratio of 32.45, a price-to-earnings-growth ratio of 1.39 and a beta of 0.72.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm had revenue of $64.01 billion for the quarter, compared to analysts’ expectations of $59.41 billion. During the same quarter last year, the company posted $1.88 earnings per share. Cardinal Health’s revenue was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Sell-side analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be issued a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend is Friday, January 2nd. Cardinal Health’s payout ratio is 30.77%.

Analysts Set New Price Targets

A number of research analysts have recently commented on CAH shares. Weiss Ratings reissued a “buy (b)” rating on shares of Cardinal Health in a research report on Wednesday, October 8th. Mizuho upped their price objective on shares of Cardinal Health from $170.00 to $210.00 and gave the company an “outperform” rating in a research report on Monday, November 3rd. Evercore ISI lifted their target price on Cardinal Health from $190.00 to $220.00 and gave the stock an “outperform” rating in a research report on Friday, October 31st. Jefferies Financial Group set a $220.00 price objective on Cardinal Health and gave the company a “buy” rating in a research note on Monday, November 3rd. Finally, Robert W. Baird set a $232.00 target price on Cardinal Health in a research note on Friday, October 31st. Twelve investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, Cardinal Health has a consensus rating of “Moderate Buy” and an average price target of $206.57.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.